News and Announcements
Idol Announce USD$1 million Investment and New Strategic Partnership
- Published July 02, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Idol announces USD$1 million investment from Stratus Capital Pte.
- They also share the news o f their partnership with Sports Capital Advisors Pte Ltd.
- Idol present their opportunity at a London roadshow
Investment Announcement
Idol is very happy to announce a USD$1 million investment from Stratus Capital Pte., a Singapore based venture capital fund. We would like to thank Stratus for their support and trust in this partnership.
Partnerships
Idol are very pleased to announce a partnership with Sports Capital Advisors Pte Ltd., the only exclusively Asian focused sports & entertainment private equity investor, specialising in buyouts, equity investments, strategic growth stage and sales consultancy.
On The Road
Last month Idol had the opportunity to present their project to a room full of investors in London! Thank you to Wholesale Investor for hosting us, we thoroughly enjoyed our stay in London. Hope to be back soon!
About Idol Entertainment:
Idol is the world’s fan-driven entertainment community, focusing on the monetization and commercialization of celebrities for fans. Built upon the Ethereum network, Idol utilizes the properties of blockchain technology and the flexibility of smart contracts to provide innovative solutions for the major key players within the entertainment industry: fans, celebrities, and entertainment companies.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
